Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis

This study is ongoing, but not recruiting participants.
Information provided by MidAmerica Neuroscience Institute

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Multiple Sclerosis
2		Additional conditions recognized in this trial
			Sclerosis
3		More general conditions related to this trial
			Autoimmune Diseases
			Autoimmune Diseases of the Nervous System
			Demyelinating Autoimmune Diseases, CNS
			Demyelinating Diseases
			Immune System Diseases
			Nervous System Diseases
			Pathologic Processes
4		Interventions listed in this trial
			interferon beta 1a
			methotrexate
5		Additional drug interventions recognized in this trial
			Interferon-beta
			Interferons
6		More general drug interventions related to this trial
			Abortifacient Agents
			Abortifacient Agents, Nonsteroidal
			Adjuvants, Immunologic
			Anti-Infective Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Antirheumatic Agents
			Antiviral Agents
			Dermatologic Agents
			Enzyme Inhibitors
			Folic Acid Antagonists
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Physiological Effects of Drugs
			Reproductive Control Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			MidAmerica Neuroscience Institute
			Consultants in Neurology
			Biogen Idec